Evidence map›Paper›PMID 30728350›Full record

ArticleCell death & disease2019

Elevated apoptosis impairs epithelial cell turnover and shortens villi in TNF-driven intestinal inflammation.

Aimée Parker, Laura Vaux, Angela M Patterson, Amisha Modasia, Daniele Muraro, Alexander G Fletcher, Helen M Byrne, Philip K Maini, Alastair J M Watson, Carmen Pin

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Barrier-Strengthening Effects of Cannabidiol on Porcine Peyer's Patches.International journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Aimée ParkerGut Health and Food Safety Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom.
Laura VauxGut Health and Food Safety Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom.
Angela M PattersonGut Health and Food Safety Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom.
Amisha ModasiaGut Health and Food Safety Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom.
Daniele MuraroWellcome Sanger Institute, Hinxton, United Kingdom.
Alexander G FletcherSchool of Mathematics and Statistics, University of Sheffield, Sheffield, United Kingdom.
Helen M ByrneWolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford, United Kingdom.
Philip K MainiWolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Oxford, United Kingdom.
Alastair J M WatsonNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Carmen PinGut Health and Food Safety Research Programme, Quadram Institute Bioscience, Norwich, United Kingdom. carmen.pin@astrazeneca.com.ORCID http://orcid.org/0000-0001-8734-6167
Quadram Institute · GBUniversity of Oxford · GBAstraZeneca (United Kingdom) · GBUniversity of East Anglia · GBUniversity of Sheffield · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J004529/1Biotechnology and Biological Sciences Research Council BB/K017144/1Biotechnology and Biological Sciences Research Council BB/K017578/1Biotechnology and Biological Sciences Research Council BB/K018256/1
6 · The paper itself

Abstract

The intestinal epithelial monolayer, at the boundary between microbes and the host immune system, plays an important role in the development of inflammatory bowel disease (IBD), particularly as a target and producer of pro-inflammatory TNF. Chronic overexpression of TNF leads to IBD-like pathology over time, but the mechanisms driving early pathogenesis events are not clear. We studied the epithelial response to inflammation by combining mathematical models with in vivo experimental models resembling acute and chronic TNF-mediated injury. We found significant villus atrophy with increased epithelial cell death along the crypt-villus axis, most dramatically at the villus tips, in both acute and chronic inflammation. In the acute model, we observed overexpression of TNF receptor I in the villus tip rapidly after TNF injection and concurrent with elevated levels of intracellular TNF and rapid shedding at the tip. In the chronic model, sustained villus atrophy was accompanied by a reduction in absolute epithelial cell turnover. Mathematical modelling demonstrated that increased cell apoptosis on the villus body explains the reduction in epithelial cell turnover along the crypt-villus axis observed in chronic inflammation. Cell destruction in the villus was not accompanied by changes in proliferative cell number or division rate within the crypt. Epithelial morphology and immunological changes in the chronic setting suggest a repair response to cell damage although the villus length is not recovered. A better understanding of how this state is further destabilised and results in clinical pathology resembling IBD will help identify suitable pathways for therapeutic intervention.

Indexed as

AnimalsApoptosisAtrophyDisease Models, AnimalEpithelial CellsFemaleHumansInflammationInflammatory Bowel DiseasesIntestinal MucosaMiceMice, Inbred C57BLTumor Necrosis FactorsTumor Necrosis Factors

Identifiers

PMID30728350
PMCPMC6365534
OpenAlexW2904894332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.